Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome [Hematologic Malignancy]
Conclusion
The proposed system is prognostic of outcome in patients undergoing HLA-matched and -mismatched allo HCT for MDS.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Shaffer, Ahn, Hu, Nishihori, Malone, Valcarcel, Grunwald, Bacher, Hamilton, Kharfan-Dabaja, Saad, Cutler, Warlick, Reshef, Wirk, Sabloff, Fasan, Gerds, Marks, Olsson, Wood, Costa, Miller, Cortes, Daly, Kindwall-Keller, Kamble, Rizzieri, Cahn, Gale, Willia Tags: Leukemia Hematologic Malignancy Source Type: research
More News: Cancer & Oncology | Hematology | Leukemia | Myelodysplastic Syndrome | Training | Transplants | Universities & Medical Training